Tome Biosciences Stock

tome.bioHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $245.57MM

Tome Biosciences is a genomic medicine company. By creating programmable gene insertion technology, Tome Biosciences has a mission to deliver patients a cure with cell technology. The company’s integrative gene therapies work by destroying deoxyribonucleic acid and inserting a genetic sequence at any location of any size. Tome Biosciences was founded by Jonathan Gootenberg and Omar Abudayyeh in 2021 and is headquartered in Boston, MA.

Register To Buy and Sell Shares

For more details on financing and valuation for Tome Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Tome Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Tome Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Tome Biosciences’ Stock

Can you buy Tome Biosciences’ stock?
Tome Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Tome Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Tome Biosciences’ stock?
Yes, you can sell stock of a private company like Tome Biosciences. Forge can help you sell your Tome Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Tome Biosciences’ stock price?
Tome Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Tome Biosciences’ private market stock price with Forge Data.
What is Tome Biosciences’ stock ticker symbol?
Tome Biosciences does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Tome Biosciences Raises Over $213M in Series A and Series B
In a duel Series A and B funding round Tome Biosciences raised $213 million for the development of integrative gene therapies.
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.